Researcher.Life Logo

European Journal of Heart Failure : Impact Factor & More

eISSN: 1879-0844pISSN: 1388-9842

Key Metrics

CiteScore
21.5
Eigenfactor
0.01 - 0.05
H-Index
156
Impact Factor
15 - 20
Scite Index
0.88 5-Year SI
SJR
Q1Cardiology and Cardiovascular Medicine
SNIP
3.48
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Journal of Heart Failure

European Journal of Heart Failure Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Journal of Heart Failure ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Journal of Heart Failure

Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy.
  • 19 May 2026
  • European journal of heart failure
Changes in Upright Hemodynamics Preceding Heart Failure Events and Other Hospitalizations.
  • 19 May 2026
  • European journal of heart failure
Reply to "Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status".
  • 18 May 2026
  • European journal of heart failure
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trial.
  • 18 May 2026
  • European journal of heart failure
Improved Outcome up to Ten Years after Intravenous Immunoglobulin Therapy in Patients with Dilated Cardiomyopathy.
  • 15 May 2026
  • European journal of heart failure
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial.
  • 15 May 2026
  • European journal of heart failure
Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy.
  • 19 May 2026
  • European journal of heart failure
Changes in Upright Hemodynamics Preceding Heart Failure Events and Other Hospitalizations.
  • 19 May 2026
  • European journal of heart failure
Reply to "Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status".
  • 18 May 2026
  • European journal of heart failure
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trial.
  • 18 May 2026
  • European journal of heart failure
Improved Outcome up to Ten Years after Intravenous Immunoglobulin Therapy in Patients with Dilated Cardiomyopathy.
  • 15 May 2026
  • European journal of heart failure
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial.
  • 15 May 2026
  • European journal of heart failure

FAQs on European Journal of Heart Failure